A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home)
Asia BP@Home
1 other identifier
observational
1,462
1 country
1
Brief Summary
Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice. Therefore, we conduct Asia BP@Home study to assess HBP control status in each Asian country and develop an Asian consensus and Asia-specific treatment for hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2017
CompletedFirst Posted
Study publicly available on registry
March 30, 2017
CompletedStudy Start
First participant enrolled
April 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2018
CompletedApril 17, 2018
April 1, 2018
12 months
March 23, 2017
April 15, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Distribution rate based on the home BP of the patients.
Distribution rate based on the home BP of the patients who are defined as: * Masked morning hypertension * White-coat hypertension * Poorly controlled hypertension * Well controlled hypertension
7 days or more blood pressure measurement
Interventions
We ask participants to measure their home blood pressure 7 days or more.
Eligibility Criteria
Inclusion criteria: 1. Age \>= 20 years 2. Subjects with stable medication (\> 3 months) diagnosed as hypertension 3. Asian 4. Subjects have been thoroughly informed about this registry and signed an Informed Consent Form.
You may qualify if:
- Age \>= 20 years
- Subjects with stable medication (\> 3 months) diagnosed as hypertension
- Asian
- Subjects have been thoroughly informed about this registry and signed an Informed Consent Form.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jichi Medical University
Tochigi, Japan
Related Publications (1)
Chia YC, Kario K, Tomitani N, Park S, Shin J, Turana Y, Tay JC, Buranakitjaroen P, Chen CH, Hoshide S, Nailes J, Minh HV, Siddique S, Sison J, Soenarta AA, Sogunuru GP, Sukonthasarn A, Teo BW, Verma N, Zhang Y, Wang TD, Wang JG. Comparison of day-to-day blood pressure variability in hypertensive patients with type 2 diabetes mellitus to those without diabetes: Asia BP@Home Study. J Clin Hypertens (Greenwich). 2020 Mar;22(3):407-414. doi: 10.1111/jch.13731. Epub 2019 Dec 31.
PMID: 31891447DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kazuomi Kario, MD, PhD
Jichi Medical University School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor & Chairman
Study Record Dates
First Submitted
March 23, 2017
First Posted
March 30, 2017
Study Start
April 6, 2017
Primary Completion
March 31, 2018
Study Completion
March 31, 2018
Last Updated
April 17, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share